Encapsulation of Cochleates Derived from <i>Salmonella</i> Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine

The aim of this study was to develop and characterize <i>Salmonella</i><i>enterica</i> serovar Infantis (<i>S.</i> Infantis) cochleates protected by encapsulation technology as a potential vaccine and to determine its safety in pullets. Cochleates were encapsulate...

Full description

Bibliographic Details
Main Authors: Constanza Avendaño, Sonia Vidal, María Gabriela Villamizar-Sarmiento, Miguel Guzmán, Héctor Hidalgo, Lisette Lapierre, Carolina Valenzuela, Leonardo Sáenz
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Polymers
Subjects:
Online Access:https://www.mdpi.com/2073-4360/13/19/3426
_version_ 1797515873063272448
author Constanza Avendaño
Sonia Vidal
María Gabriela Villamizar-Sarmiento
Miguel Guzmán
Héctor Hidalgo
Lisette Lapierre
Carolina Valenzuela
Leonardo Sáenz
author_facet Constanza Avendaño
Sonia Vidal
María Gabriela Villamizar-Sarmiento
Miguel Guzmán
Héctor Hidalgo
Lisette Lapierre
Carolina Valenzuela
Leonardo Sáenz
author_sort Constanza Avendaño
collection DOAJ
description The aim of this study was to develop and characterize <i>Salmonella</i><i>enterica</i> serovar Infantis (<i>S.</i> Infantis) cochleates protected by encapsulation technology as a potential vaccine and to determine its safety in pullets. Cochleates were encapsulated by two technologies, spray drying and ionotropic gelation at different concentrations (0–15% v/v), and were characterized by physicochemical properties, protein content and Fourier Transform Infrared Spectroscopy (FTIR). The cochleates were white liquid suspensions with tubular shapes and a protein content of 1.0–2.1 mg/mL. After encapsulation by spray drying, microparticles ranged in size from 10.4–16.9 µm, were spherical in shape, and the protein content was 0.7–1.8 mg/g. After encapsulation by ionotropic gelation, beads ranged in size from 1620–1950 µm and were spherical in shape with a protein content of 1.0–2.5 mg/g. FTIR analysis indicated that both encapsulation processes were efficient. The cochleates encapsulated by ionotropic gelation were then tested for safety in pullets. No ill effect on the health of animals was observed upon physical or postmortem examination. In conclusion, this study was the first step in developing a potential oral <i>S.</i> Infantis vaccine safe for poultry using a novel cochleate encapsulation technology. Future studies are needed to determine the effectiveness of the vaccine.
first_indexed 2024-03-10T06:53:23Z
format Article
id doaj.art-c08a4c11cc4d44dbb210e68213cc0092
institution Directory Open Access Journal
issn 2073-4360
language English
last_indexed 2024-03-10T06:53:23Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Polymers
spelling doaj.art-c08a4c11cc4d44dbb210e68213cc00922023-11-22T16:40:29ZengMDPI AGPolymers2073-43602021-10-011319342610.3390/polym13193426Encapsulation of Cochleates Derived from <i>Salmonella</i> Infantis with Biopolymers to Develop a Potential Oral Poultry VaccineConstanza Avendaño0Sonia Vidal1María Gabriela Villamizar-Sarmiento2Miguel Guzmán3Héctor Hidalgo4Lisette Lapierre5Carolina Valenzuela6Leonardo Sáenz7Faculty of Veterinary Sciences, University of Chile, Santiago 8820808, ChileFaculty of Veterinary Sciences, University of Chile, Santiago 8820808, ChileFaculty of Veterinary Sciences, University of Chile, Santiago 8820808, ChileFaculty of Veterinary Sciences, University of Chile, Santiago 8820808, ChileFaculty of Veterinary Sciences, University of Chile, Santiago 8820808, ChileFaculty of Veterinary Sciences, University of Chile, Santiago 8820808, ChileFaculty of Veterinary Sciences, University of Chile, Santiago 8820808, ChileFaculty of Veterinary Sciences, University of Chile, Santiago 8820808, ChileThe aim of this study was to develop and characterize <i>Salmonella</i><i>enterica</i> serovar Infantis (<i>S.</i> Infantis) cochleates protected by encapsulation technology as a potential vaccine and to determine its safety in pullets. Cochleates were encapsulated by two technologies, spray drying and ionotropic gelation at different concentrations (0–15% v/v), and were characterized by physicochemical properties, protein content and Fourier Transform Infrared Spectroscopy (FTIR). The cochleates were white liquid suspensions with tubular shapes and a protein content of 1.0–2.1 mg/mL. After encapsulation by spray drying, microparticles ranged in size from 10.4–16.9 µm, were spherical in shape, and the protein content was 0.7–1.8 mg/g. After encapsulation by ionotropic gelation, beads ranged in size from 1620–1950 µm and were spherical in shape with a protein content of 1.0–2.5 mg/g. FTIR analysis indicated that both encapsulation processes were efficient. The cochleates encapsulated by ionotropic gelation were then tested for safety in pullets. No ill effect on the health of animals was observed upon physical or postmortem examination. In conclusion, this study was the first step in developing a potential oral <i>S.</i> Infantis vaccine safe for poultry using a novel cochleate encapsulation technology. Future studies are needed to determine the effectiveness of the vaccine.https://www.mdpi.com/2073-4360/13/19/3426cochleateencapsulationpoultry<i>Salmonella</i> Infantisvaccine
spellingShingle Constanza Avendaño
Sonia Vidal
María Gabriela Villamizar-Sarmiento
Miguel Guzmán
Héctor Hidalgo
Lisette Lapierre
Carolina Valenzuela
Leonardo Sáenz
Encapsulation of Cochleates Derived from <i>Salmonella</i> Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine
Polymers
cochleate
encapsulation
poultry
<i>Salmonella</i> Infantis
vaccine
title Encapsulation of Cochleates Derived from <i>Salmonella</i> Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine
title_full Encapsulation of Cochleates Derived from <i>Salmonella</i> Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine
title_fullStr Encapsulation of Cochleates Derived from <i>Salmonella</i> Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine
title_full_unstemmed Encapsulation of Cochleates Derived from <i>Salmonella</i> Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine
title_short Encapsulation of Cochleates Derived from <i>Salmonella</i> Infantis with Biopolymers to Develop a Potential Oral Poultry Vaccine
title_sort encapsulation of cochleates derived from i salmonella i infantis with biopolymers to develop a potential oral poultry vaccine
topic cochleate
encapsulation
poultry
<i>Salmonella</i> Infantis
vaccine
url https://www.mdpi.com/2073-4360/13/19/3426
work_keys_str_mv AT constanzaavendano encapsulationofcochleatesderivedfromisalmonellaiinfantiswithbiopolymerstodevelopapotentialoralpoultryvaccine
AT soniavidal encapsulationofcochleatesderivedfromisalmonellaiinfantiswithbiopolymerstodevelopapotentialoralpoultryvaccine
AT mariagabrielavillamizarsarmiento encapsulationofcochleatesderivedfromisalmonellaiinfantiswithbiopolymerstodevelopapotentialoralpoultryvaccine
AT miguelguzman encapsulationofcochleatesderivedfromisalmonellaiinfantiswithbiopolymerstodevelopapotentialoralpoultryvaccine
AT hectorhidalgo encapsulationofcochleatesderivedfromisalmonellaiinfantiswithbiopolymerstodevelopapotentialoralpoultryvaccine
AT lisettelapierre encapsulationofcochleatesderivedfromisalmonellaiinfantiswithbiopolymerstodevelopapotentialoralpoultryvaccine
AT carolinavalenzuela encapsulationofcochleatesderivedfromisalmonellaiinfantiswithbiopolymerstodevelopapotentialoralpoultryvaccine
AT leonardosaenz encapsulationofcochleatesderivedfromisalmonellaiinfantiswithbiopolymerstodevelopapotentialoralpoultryvaccine